AJP - Heart Calcium Transients and Cell-Sarcomere
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 277: H2176-H2184, 1999;
0363-6135/99 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nagatomo, Y.
Right arrow Articles by McDermott, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nagatomo, Y.
Right arrow Articles by McDermott, P. J.
Vol. 277, Issue 6, H2176-H2184, December 1999

Translational mechanisms accelerate the rate of protein synthesis during canine pressure-overload hypertrophy

Yoshitatsu Nagatomo, Blase A. Carabello, Masayoshi Hamawaki, Shintaro Nemoto, Takeshi Matsuo, and Paul J. McDermott

Department of Medicine and the Gazes Cardiac Research Institute, Medical University of South Carolina, and Ralph H. Johnson Veterans Affairs Medical Center, Charleston, South Carolina 29403


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

This study examined how translational mechanisms regulate the rate of cardiac protein synthesis during canine pressure overload in vivo. Acute aortic stenosis (AS) was produced by inflating a balloon catheter in the ascending aorta for 6 h; sustained AS was created by controlled banding of the ascending aorta. AS caused significant hypertrophy as reflected by increased left ventricular (LV) mass after 5 and 10 days. To monitor LV protein synthesis in vivo, myosin heavy chain (MHC) synthesis was measured by continuous infusion of radiolabeled leucine. Acute AS accelerated the rate of myosin synthesis without a corresponding increase in ribosomal RNA, indicating an increase in translational efficiency. Total MHC synthesis (mg MHC/LV per day) was significantly increased at 5 and 10 days of sustained AS. Total MHC degradation was not significantly altered at 5 days of AS but increased at 10 days of AS in concordance with a new steady state with respect to growth. Translational capacity (mg total RNA/LV) was significantly increased after 5 and 10 days of AS and was preceded by an increase in the rate of ribosome formation. MHC mRNA levels remained unchanged during AS. These findings demonstrate that cardiac protein synthesis is accelerated in response to pressure overload by an initial increase in translational efficiency, followed by an adaptive increase in translational capacity during sustained hypertrophic growth.

pressure overload; translation; eukaryotic initiation factor 4E


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

HYPERTROPHY is the primary mechanism by which the adult myocardium compensates for hemodynamic overload (10). Hypertrophy is thought to be initiated by an increase in myocardial wall stress as defined by the Laplace equation in which wall stress is calculated as (pressure × radius)/(2 × wall thickness) (13). It has been postulated that, in pressure overload, the increase in pressure in the numerator of the equation increases systolic wall stress, thereby initiating the development of concentric hypertrophy and increasing the thickness of the myocardial wall. This increase in wall thickness offsets the increase in systolic pressure and maintains wall stress within the normal range. In volume overload, increased diastolic stress is thought to trigger the development of eccentric hypertrophy in which lengthening of the cardiac muscle cells leads to chamber enlargement.

The myocardial proteins are in a constant dynamic state of synthesis and degradation when the myocardium is in a steady state with respect to growth (31). For hypertrophy to occur, the net balance between protein synthesis and protein degradation must be altered, by either accelerating the rate of protein synthesis or decreasing the rate of protein degradation. In the volume overload of mitral regurgitation, we have shown that the rate of protein synthesis was not accelerated and that hypertrophic growth was attributable to a decrease in the rate of protein degradation (24). The amount of hypertrophy produced by volume overload is generally less than that produced by pressure overload (5). In contrast, our study of acute aortic stenosis (AS) showed a marked acceleration of the rate of protein synthesis, which occurred without an increase in either the ribosomal RNA pool or in mRNA levels (17). This response to acute pressure overload is indicative of an increase in translational efficiency, defined as the utilization of the mRNA pool by the preexisting translational machinery in the adult myocardium. Similar increases in efficiency have been observed in other models of pressure overload (9, 27, 32). Translational mechanisms are also known to have a central role in accelerating protein synthesis rates during sustained pressure overload. During the growth phase of pressure-overload hypertrophy, there is a well-established increase in the capacity for protein synthesis as defined by the amount of translational machinery, including ribosomes, tRNA, and initiation and elongation factors (31). However, the precise roles of translational efficiency and capacity in controlling the hypertrophic process in pressure overload have never been studied in a unified fashion from the initiation of hypertrophy to the achievement of a new steady state in a large animal model of gradual stenosis such as that seen in humans.

We have recently developed a canine model of aortic stenosis in which pressure overload is controlled by an externally controlled aortic band (23). After an increase in stenosis severity, there is a detectable increase in cardiac mass by 24 h, followed by linear growth that reaches a new steady state in 10 days. We hypothesized that the role of translational efficiency is to accelerate the rate of protein synthesis in response to the initial increase in systolic wall stress, whereas the role of capacity is to produce an overall increase in translational machinery and thereby maintain accelerated protein synthesis rates during sustained hypertrophic growth. The rate of myosin heavy chain (MHC) synthesis was used as a specific marker of protein synthesis in vivo. The hypothesis was tested by examining translational regulation in the canine left ventricle (LV) at three phases of pressure overload: the acute phase (6 h), the rapid growth phase (5 days), and the steady-state phase of hypertrophy (10 days). To determine the linkage between increased systolic wall stress and accelerated rates of cardiac protein synthesis, two key mechanisms for increasing translational efficiency and capacity were examined: 1) changes in the activity of eukaryotic initiation factor 4E (eIF4E) as measured by its phosphorylation and 2) changes in the rate of 60S ribosome formation and net accumulation of rRNA.


    METHODS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Models of canine pressure overload. All procedures were done in accordance to institutional guidelines. Five adult mongrel dogs were used as controls. Anesthesia was induced with an infusion of 0.15 mg · kg-1 · min-1 sufentanil supplemented by isoflurane and maintained by a constant infusion of sufentanil and a low dose of isoflurane by inhalation. A thermodilution Swan-Ganz catheter was inserted via the femoral vein for measuring pulmonary capillary wedge pressure, pulmonary artery pressure, and cardiac output. A second catheter was placed in the femoral artery for measuring arterial blood pressure.

Both acute and chronic models of canine LV pressure overload were produced by aortic stenosis. The dogs were matched for age and sex with the controls. Acute pressure overload was produced using a balloon catheter as described previously (17). A pacemaking wire was inserted into the right atrium from the left femoral vein, and pacing was maintained at 100 beats/min to prevent the reflex bradycardia that can occur when the aortic balloon catheter is inflated. The aortic balloon catheter was inflated to increase LV peak systolic pressure to 175-200 mmHg, and then radiolabeling experiments proceeded over 6 h.

The chronic LV pressure-overload model was produced as described previously (23). Pressure was increased after 2 wk; LV pressure, descending aortic pressure, and cardiac output were subsequently measured. Blood pressure was measured distal to the coarctation. Studies of protein synthesis were performed 5 and 10 days after the second incremental inflation because previous studies demonstrated that hypertrophic growth occurred during this period (23). At the time of protein synthesis determination, anesthesia was administered as described above and contrast left ventriculography was performed. LV mass was calculated using the method of Rackley et al. (35), which has been validated in our laboratory (4, 11, 33). Our previous work has shown that the correlation between LV mass as determined by ventriculography and actual LV mass as determined at necropsy can be described by the linear function y = -0.226 + 0.984x (R = 0.96), where y is the LV mass determined by ventriculography and x is the actual LV mass (4). Total stroke volume was quantified by contrast left ventriculography and thermodilution cardiac output.

Continuous infusion of radiolabeled leucine. Hearts were radiolabeled by continuous infusion with L-[3,4,5-3H(N)]leucine over 6 h as described previously (24). In the acute AS experiments, infusion was begun as soon as the hemodynamic conditions were stable. Blood samples were withdrawn from the ascending aorta at regular intervals for measurement of plasma leucine-specific radioactivity. When the infusion period was completed, the hearts were rapidly removed and rinsed in ice-cold saline, and the great vessels were perfused retrogradely with ice-cold saline. For measurements of the rate of ribosome formation, portions of the LV free wall were minced and homogenized immediately. The remaining heart tissue was frozen in liquid nitrogen and stored. Samples of frozen LV and RV free wall were used to measure the rate of MHC synthesis, MHC mRNA levels, MHC content, and total RNA content.

Determination of plasma leucine-specific radioactivity. Blood samples were centrifuged, and perchloric acid (PCA) was added to a final concentration of 6%. The plasma proteins were pelleted by centrifugation. The supernatant was neutralized by addition of KOH, centrifuged, and dried by vacuum centrifugation. The sample was resuspended in 0.1 M NaHCO3-Na2CO3 buffer, pH 9.5, and reacted with an equal volume of 5 mM [14C-methyl]dansyl chloride (110-120 mCi/mmol) at 37°C for 1 h. The dansylated amino acids were purified by two-dimensional thin-layer chromatography on micropolyamide plates as described previously (1). The 3H-to-14C ratio of the dansyl-leucine spot was used to calculate the plasma leucine-specific radioactivity.

Determination of MHC synthesis rates. The fractional rate of MHC synthesis (Ks) was determined by the continuous infusion method using the following formula
<IT>K</IT><SUB>s</SUB> = <FR><NU>P*</NU><DE><LIM><OP>∫</OP></LIM> F* d<IT>t</IT></DE></FR>
where P* is the specific radioactivity of leucine in MHC and <LIM><OP>∫</OP></LIM>F*dt is the plasma leucine-specific radioactivity time curve. MHC was purified as described previously (17) and the specific radioactivity of leucine in MHC was measured by the dansyl-chloride method.

Measurement of rate of ribosome formation. The rate of 60S ribosome formation was determined by measuring the rate of incorporation of [3H]leucine into protein of purified 60S ribosomes and dividing by the specific radioactivity of the plasma leucine pool (24, 37). Rates of 60S ribosome formation were calculated using the following formula


<FR><NU>[Radioactivity of 60S peak (dpm) − background radioactivity (dpm)]</NU><DE>(Protein content of 60S peak − background protein content)</DE></FR> × <FENCE><LIM><OP>∫</OP></LIM> F* d<IT>t</IT></FENCE><SUP>−1</SUP>

Background radioactivity and background protein content were determined by extrapolation of baseline radioactivity and protein content immediately before and after the 60S peak.

Measurement of RNA content, total protein content, and MHC content. Total RNA content in the supernatant was determined spectrophotometrically at a wavelength of 260 nm as described previously (37). For measuring total protein content, the residual pellet was washed three times with 0.2 N PCA, resuspended with 0.3 N NaOH, and incubated at 37°C overnight. The concentration of total protein content was measured by the bicinchoninic acid method (Pierce, Rockford, IL). MHC content was measured as described previously (24).

Determination of MHC mRNA levels. RNA was extracted using the guanidinium thiocyanate method (8). Slot-blot hybridization analysis was carried out using a 32P-labeled feline MHC cDNA probe as described previously (24). The autoradiograms were analyzed by digital image analysis using NIH Image software. The optical densities of the hybridization signals were in the linear range.

Measurement of eIF4E phosphorylation. Portions of frozen LV (100 mg) were homogenized in lysis cell buffer (LCB) [20 mM HEPES, pH 7.5, 100 mM KCl, 0.2 mM EDTA, 7 mM beta -mercaptoethanol, 10% (vol/vol) glycerol, 0.5% (vol/vol) Triton X-100, 80 mM 2-glycerophosphate, 50 mM NaF, 0.2 mM phenylmethylsulfonyl fluoride, 1 mM benzamidine, 0.5 mM sodium orthovanadate, 1 µM okadaic acid, 1 µM microcystin LR, 25 µg/ml leupeptin, 2 U/ml aprotinin, and 20 µg/ml chymostatin] and centrifuged at 12,000 g for 10 min. Twenty microliters of washed m7GTP-Sepharose 4B (Pharmacia) were added to the supernatant and incubated for 1 h at 4°C. The m7GTP-Sepharose was pelleted and washed three times with LCB. The phosphorylation state of eIF4E was determined by vertical slab gel isoelectric focusing and Western blotting as described previously (40). The percentage of phosphorylated eIF4E was quantified by digital image analysis.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Hemodynamics of experimental pressure overload. In Table 1, hemodynamic data for the control and AS dogs are shown. Hemodynamic measurements were taken at hourly intervals during continuous infusion and averaged. Heart rate was increased as a result of pacemaker implementation to ~100 beats/min and was maintained over the duration of AS. Systolic and diastolic blood pressure were significantly lower during the acute AS procedure but were normal as measured after 5 and 10 days of sustained AS. The severity of pressure overload was demonstrated by a significant 60% increase in LV systolic pressure in the acute AS model and increases of 75% and 72% after 5 and 10 days of AS, respectively. Pulmonary capillary wedge pressure was significantly increased but remained within the normal range for our laboratory. Pulmonary artery systolic pressure was increased by an average of 17%, but these increases were not statistically different compared with controls. Stroke volume was decreased significantly at 5 days of AS but increased toward the control value by 10 days of AS, indicating that the LV compensated for the sustained increase in afterload. Table 1 also shows that there were no significant differences in body weight between control and AS dogs at any experimental time point.

                              
View this table:
[in this window]
[in a new window]
 
Table 1.   Hemodynamics of experimental aortic stenosis

Development of pressure-overload hypertrophy. Changes in LV mass were determined by ventriculography. The baseline value for LV mass was measured in each dog before the increase in pressure gradient. As shown in Fig. 1, LV mass was significantly increased by 11.1% and 26.4% after 5 and 10 days of AS, respectively. There were corresponding increases in the LV mass-to-body weight ratio of 15.1% and 28.1%, confirming that compensatory LV hypertrophy occurred in response to sustained pressure overload. Body weight did not change from baseline values during experimental AS, indicating that the adult dogs were in a steady state with respect to growth (23.1 ± 1.0 kg at baseline vs. 22.9 ± 1.3 kg after 5 days of AS; 21.2 ± 1.0 kg at baseline vs. 21.5 ± 1.1 kg after 10 days of AS).


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 1.   Cardiac hypertrophy in dogs in response to experimental pressure overload. A: for both groups of dogs, left ventricular (LV) mass was determined by ventriculography at baseline and after 5 (5-day AS) and 10 days of aortic stenosis (10-day AS). B: LV mass normalized to body weight in same dogs. Values are means ± SE. * P < 0.05; dagger  P < 0.07 vs. corresponding baseline value as determined by a paired t-test.

Specific radioactivity of precursor pool during continuous infusion. Plasma leucine-specific radioactivity equilibrates with leucyl-tRNA-specific radioactivity in the canine LV during continuous infusion (17) and was therefore used as the precursor pool for calculating the rate of MHC synthesis and the rate of 60S ribosome formation. Figure 2 shows the plasma leucine-specific radioactivity time curve during 6 h of continuous infusion with [3H]leucine in control and AS dogs. In each experimental group, the plasma leucine-specific radioactivity rose rapidly during the first 30 min and plateaued to a constant value over the remainder of the infusion period. There were no significant differences in plasma leucine-specific radioactivity in the control dogs compared with any of the AS groups.


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 2.   Plasma leucine-specific radioactivity during continuous infusion with [3H]leucine. Values are means ± SE for each experimental group of dogs during continuous infusion.

Effect of pressure overload on rate of protein synthesis. The anabolic effects of AS on cardiac protein synthesis were determined by measuring Ks. Figure 3A shows that MHC Ks was significantly increased by 29% in response to acute pressure overload compared with control. MHC Ks decreased after 5 days of pressure overload and slowed to the control value by 10 days. In Fig. 3B, the rate of total MHC synthesis after 5 and 10 days of AS was calculated by multiplying Ks (%/day) by the corresponding value for total MHC content per LV [(mg MHC/g LV protein) × g LV]. This calculation takes into account the increase in LV mass that occurs during pressure-overload hypertrophy. Accordingly, the rate of total MHC synthesis was increased by 87% and 63% after 5 and 10 days of AS, respectively.


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 3.   Rates of myosin heavy chain (MHC) synthesis during pressure-overload hypertrophy. A: MHC fractional rate of synthesis (Ks) values were measured in each experimental group of dogs by continuous infusion method. B: rates of total MHC synthesis and MHC degradation were calculated in control dogs and in dogs after 5 and 10 days of AS as described in text. Values are means ± SE. * P < 0.05, significantly greater than control as determined by ANOVA followed by Dunnett's test.

Effect of pressure overload on rate of protein degradation. The fractional rate of MHC degradation (Kd) can be calculated indirectly using the formula Kg = Ks - Kd, where Kg is the fractional rate of MHC accumulation. We calculated MHC Kd at 5 days of AS because prior studies using serial echocardiography showed that LV hypertrophy in the AS dogs occurred as a linear function over the first 9 days (23). Kg was determined at the 5-day time point by fitting growth to a linear function and dividing the rate of growth (g LV/day) by the corresponding value for LV mass (g). The Kg value derived from LV mass was substituted for MHC Kg because MHC protein as a fraction of total LV protein remained constant. The calculated MHC Kd after 5 days of AS was 1.14%/day, a value lower than the control value of 2.63%/day. Thus, whereas MHC Ks was increased during the growth phase of AS-induced hypertrophy, MHC Kd was decreased. The rate of total MHC degradation, calculated by multiplying Kd by total MHC content per LV, was decreased after 5 days of AS, but it was not significantly different from that in the control (Fig. 3B). LV growth reached a plateau after 10 days of AS, which is indicative of a new steady state (23). Accordingly, Fig. 3B shows that MHC degradation increased and became equivalent to MHC synthesis after 10 days of AS.

Capacity for protein synthesis during pressure-overload hypertrophy. Total RNA content is a well-described marker for changes in translational capacity of cardiac muscle because ribosomal RNA is ~85% of the total RNA pool. Figure 4A shows that RNA content normalized to total protein increased after 5 days of AS and that the increase was maintained at 10 days of AS. In Fig. 4B, the overall increase in translational capacity during hypertrophic growth was calculated by multiplying RNA content (mg RNA/g LV protein) by the corresponding values for LV mass (g). Pressure overload caused a sustained increase in capacity as indicated by a 64% and 71% increase in RNA content per LV after 5 and 10 days of AS, respectively. To determine the mechanism for rRNA accumulation, the rate of 60S ribosome formation was measured during pressure-overload hypertrophy (Fig. 4C). The rate of ribosome formation was significantly accelerated in response to acute AS but returned to the control value after 5 days. Given that the half-life of the ribosome is ~10-12 days, these data suggest that the early increase in ribosome formation accounted for the accumulation in RNA content that occurred by 5 days of pressure-overload hypertrophy.


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 4.   Effects of pressure overload on translational capacity for protein synthesis. A: total RNA normalized to total LV protein in each experimental group of dogs. B: translational capacity as calculated by total RNA content per LV in control dogs and in dogs after 5 and 10 days of AS. C: rates of 60S ribosome formation in each experimental group of dogs. Leu, leucine. Values are means ± SE. * P < 0.05, significantly greater than control as determined by ANOVA followed by Dunnett's test.

Efficiency of protein synthesis during pressure-overload hypertrophy. Translational efficiency is defined as the rate of protein synthesis normalized to the amount of translational machinery, in particular, the ribosome pool (31). To calculate translational efficiency, the rate of MHC synthesis at each time point of AS was divided by total RNA content (Fig. 5A). These data show that translational efficiency was increased in response to acute AS because the rate of MHC synthesis was accelerated before an increase in RNA content. Figure 5A also shows that translational efficiency progressively decreased after 5 and 10 days of AS in association with a corresponding increase in translational capacity. These data indicate that once the increase in capacity has occurred, steady-state levels of translational efficiency are sufficient to maintain the accelerated rate of total MHC synthesis in the hypertrophied LV.


View larger version (27K):
[in this window]
[in a new window]
 
Fig. 5.   Effects of pressure overload on translational efficiency for protein synthesis. A: translational efficiency was calculated in each group of dogs by dividing rate of MHC synthesis by total RNA content. B: representative slot-blot experiment showing MHC mRNA and 28S rRNA levels in control and AS dogs. RNA from both right ventricle (RV) and LV was labeled between duplicate samples of each experimental group. Exposure time of autoradiograms was 24 h for MHC mRNA and 1 h for 28S rRNA. Con, control; A-AS, dogs with acute AS; 5D-AS, dogs after 5 days of AS; 10D-AS, dogs after 10 days of AS. C: summary data for all dogs. MHC mRNA-to-28S rRNA ratios in LV were normalized to companion RV. Values are means ± SE. * P < 0.05, significantly greater than control as determined by ANOVA followed by Dunnett's test.

To confirm that the rate of MHC synthesis was accelerated via an increase in translational efficiency, the MHC mRNA-to-28S rRNA ratio was measured and used as an index of MHC mRNA abundance. As shown in Fig. 5B, MHC mRNA levels were measured by slot blotting using a beta -MHC cDNA probe. The blots were then stripped and hybridized with a 28S rDNA probe. The data for all dogs were summarized in Fig. 5C by normalizing the MHC mRNA-to-28S rRNA ratio in the LV to the corresponding ratio measured in the companion RV of each heart, which is normally loaded and serves as an internal control. These data show that MHC mRNA levels relative to 28S rRNA did not change significantly at any time point in the AS dogs and that the rate of MHC synthesis was accelerated during acute AS without a corresponding increase in the relative abundance of the MHC mRNA pool. Although there was not a selective induction of MHC mRNA during chronic AS, the overall size of the MHC mRNA pool in the LV increased because of the corresponding increase in total RNA per LV (see Fig. 4). These data are consistent with the high levels of efficiency observed in response to acute AS and with the return to steady-state levels of efficiency as the MHC mRNA and ribosome pools expand coordinately during hypertrophic growth.

Effect of pressure overload on eIF4E activity. eIF4E is involved in controlling the binding of mRNA to the 40S ribosomal subunit, a rate-limiting step during the process of translational initiation. Phosphorylation of eIF4E enhances its affinity for the 7-methylguanosine cap on the mRNA molecules. In Fig. 6, phosphorylation of eIF4E in canine LV was used as a marker to assess changes in the activity of eIF4E. Acute AS increased the extent of eIF4E phosphorylation to 24% compared with 8% in the LV of controls, and this increase was maintained during sustained pressure overload. These findings suggest that eIF4E activity as measured by phosphorylation correlated with the initial increase in translational efficiency and that eIF4E activity remained elevated as translational capacity increased during pressure-overload hypertrophy. The relative amount of eIF4E protein, normalized to total LV protein, did not change during pressure-overload hypertrophy (data not shown).


View larger version (30K):
[in this window]
[in a new window]
 
Fig. 6.   Effects of pressure overload on eukaryotic initiation factor 4E (eIF4E) phosphorylation. eIF4E was extracted from LV samples and the nonphosphorylated and phosphorylated (eIF4E-P) isoforms were resolved by isoelectric focusing followed by Western blotting. A: representative immunoblot containing samples from control and AS dogs. B: summary data. Values represent means ± SE of relative percentage of phosphorylated eIF4E as measured by digital image analysis of corresponding autoradiograms. * P < 0.05, significantly greater than control as determined by ANOVA followed by Dunnett's test.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

A direct comparison between pressure and volume overload suggests that increased wall stress particular to each type of mechanical overload is the primary determinant of the hypertrophic phenotype (5, 13). In the case of LV pressure-overload hypertrophy, the molecular basis for altering the phenotype can be found in two distinct processes. The first is increased expression of specific mRNAs encoding proteins that directly affect cardiac growth and function. These include diverse classes of proteins such as transcription factors (20), growth factors (3), tubulin (38), and fetal isoforms of the myofibrillar proteins myosin and actin (7). The second process involves acceleration of the rate of protein synthesis to produce an overall increase in LV mass (31). The resultant hypertrophy of the individual cardiac muscle cells is characterized by increases in constitutively expressed proteins such as myosin and actin. The interplay of these two processes during hypertrophy enables plasticity of the cardiac phenotype in the setting of a compensatory increase in LV mass.

With the use of MHC as a specific marker of cardiac protein synthesis in vivo, MHC synthesis was accelerated by pressure overload without any measurable changes in MHC mRNA abundance. This study shows that translational mechanisms coordinately accelerate the rate of protein synthesis during pressure-overload hypertrophy. The role of translational efficiency is to accelerate the rate of protein synthesis in response to the initial increase in systolic wall stress, whereas the role of capacity is to maintain accelerated rates of protein synthesis during hypertrophic growth, thereby producing a new steady state. The efficiency of protein synthesis in adult myocardium is quite high even during steady-state conditions; ~80% of the ribosome pool can be found in the actively translating 80 S and polysome fractions (30, 31). Thus the potential to accelerate the rate of protein synthesis during sustained hypertrophic growth is limited. A new steady-state protein synthesis rate can be maintained in the hypertrophied myocardium via the combination of its normally high levels of efficiency and the increase in translational capacity. This conclusion is supported by the data in Fig. 3B showing that total MHC synthesis rates are maintained at a higher steady-state value during sustained pressure-overload hypertrophy, even though efficiency has returned to the control level.

Previous studies have established a role for translational efficiency in accelerating protein synthesis in response to pressure overload in vivo (17, 27, 32). An increase in efficiency likewise accelerated the rate of protein synthesis when adult cardiac muscle cells in vitro were subjected to acute increases in load, in the form of either electrically stimulated contraction or passive stretch on a deformable membrane (18, 19, 22). The translational efficiency of protein synthesis is usually determined by the rate-limiting reactions governing peptide chain initiation, and efficiency can be improved by increasing the activity of initiation factors (16). In the process of translational initiation, binding of eIF4E to the 7-methylguanosine cap of mRNA is required for the translationally active eIF4F complex to perform its functions of unwinding mRNA secondary structure and promoting binding of mRNA to the 40S ribosomal subunit. Phosphorylation of eIF4E on the serine-209 residue increases binding affinity for the 7-methylguanosine cap present on virtually all mRNA molecules and stabilizes the translationally active eIF4F complex (2, 21, 28). The positive correlation between pressure overload and eIF4E phosphorylation is a potential mechanism for increasing efficiency of protein synthesis in the cardiac muscle cell. Our previous studies showed that acute pressure overloading of the LV produced by AS increased eIF4E phosphorylation but that acute volume overload of the LV did not stimulate eIF4E phosphorylation (40). The present studies show that the acute increase in eIF4E phosphorylation was sustained during chronic AS and suggest that eIF4E phosphorylation may have several roles in regulating the rate of protein synthesis during pressure-overload hypertrophy. Initially, eIF4E phosphorylation may increase translational efficiency in response to acute pressure overload. The persistent increase in eIF4E phosphorylation during chronic AS may serve the function of maintaining steady-state levels of translational efficiency as the capacity increases during sustained hypertrophic growth.

The acceleration of MHC synthesis in response to pressure overload did not involve selective upregulation of MHC mRNA levels in the canine myocardium. Rather, the MHC mRNA pool increased in proportion to the ribosome pool during hypertrophic growth. These observations underscore an important distinction between changes in the relative expression of alpha - and beta -MHC mRNA isoforms that occur in rodent models of pressure-overload hypertrophy and actual net increases in the total MHC mRNA levels. It is well established that transcriptional and posttranscriptional mechanisms control expression of MHC isoforms during pressure-overload hypertrophy in rats via alterations in the relative abundance of the corresponding MHC mRNA (6, 15, 29, 34). However, there is no shift in MHC isoform composition during hypertrophy of the canine LV because beta -MHC is constitutively expressed as the predominant isoform, similar to other large mammalian species, including humans (39). To our knowledge, there are no data employing any large mammalian model of LV hypertrophy proving that the overall rate of MHC synthesis is controlled by selectively increasing the size of the MHC mRNA pool. A recent study (41) showed that banding of the ascending aorta in adult rats produced hypertrophy without an increase in beta -MHC mRNA levels, yet expression of beta -MHC protein was increased. This study also revealed that selective increases in beta -MHC mRNA levels after constriction of the abdominal aorta proximal to the renal arteries may result from activation of the renin-angiotensin system, suggesting that beta -MHC mRNA expression can be dissociated from the increase in MHC synthesis that occurs in response to pressure overload. Thus the mechanical stimulus of pressure overload produced by constriction of the ascending aorta in either rat or dog is apparently sufficient to produce LV hypertrophy and demonstrates that selective induction of beta -MHC mRNA is not required to accelerate the rate of MHC synthesis.

Sustained pressure overload triggered an increase in total RNA content, a standard index of the translational capacity in adult myocardium. The accumulation of RNA was attributable to an increase in the rate of ribosome formation that occurred after 6 h of pressure overload. It has been shown that cardiac muscle can increase capacity in response to load by altering one or more of the reactions involved in ribosome formation (9, 37). For example, the onset of pressure overload in vivo increased 28S rRNA synthesis (36) and the activity of RNA polymerase I, the enzyme that transcribes rDNA (12). These observations were confirmed using neonatal rat myocytes in vitro (25, 26). More recent findings (14) suggest that capacity is increased during growth of neonatal rat myocytes via the activity of UBF, a DNA binding protein that regulates transcription of the rDNA genes.

We conclude that translational mechanisms coordinately regulate the rate of protein synthesis during hypertrophy induced by a stepwise increase in LV pressure overload. The rate of protein synthesis is accelerated by an increase in translational efficiency and is maintained at a higher steady state by an adaptive increase in translational capacity during sustained hypertrophic growth.


    ACKNOWLEDGEMENTS

We thank Gilberto DeFreyte for excellent technical assistance.


    FOOTNOTES

This work was supported by National Heart, Lung, and Blood Institute Grant P01-HL-48788 and the Research Service of the Department of Veterans Affairs.

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.

Address for reprint requests and other correspondence: P. J. McDermott, Gazes Cardiac Research Institute, Rm. 303, Strom Thurmond Biomedical Research Bldg., 114 Doughty St., Charleston, SC 29403 (E-mail: mcdermp{at}musc.edu).

Received 8 February 1999; accepted in final form 17 June 1999.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

1.   Airhart, J., S. Sibiga, H. Sanders, and E. A. Khairallah. An ultramicro method for quantification of amino acids in biologic fluids. Anal. Biochem. 53: 132-140, 1973[Medline].

2.   Bu, X., D. W. Haas, and C. H. Hagedorn. Novel phosphorylation sites of eukaryotic initiation factor-4F and evidence that phosphorylation stabilizes interactions of the p25 and p220 subunits. J. Biol. Chem. 268: 4975-4978, 1993[Abstract/Free Full Text].

3.   Calderone, A., N. Takahashi, N. J. Izzo, C. M. Thaik, and W. S. Colucci. Pressure- and volume-induced left ventricular hypertrophies are associated with distinct myocyte phenotypes and differential induction of peptide growth factor mRNAs. Circulation 92: 2385-2390, 1995[Abstract/Free Full Text].

4.   Carabello, B. A., K. Nakano, W. Corin, R. Biederman, and J. F. Spann, Jr. Left ventricular function in experimental volume overload hypertrophy. Am. J. Physiol. 256 (Heart Circ. Physiol. 25): H974-H981, 1989[Abstract/Free Full Text].

5.   Carabello, B. A., M. R. Zile, R. Tanaka, and G. Cooper IV. Left ventricular hypertrophy due to volume overload versus pressure overload. Am. J. Physiol. 263 (Heart Circ. Physiol. 32): H1137-H1144, 1992[Abstract/Free Full Text].

6.   Chassagne, C., C. Wisnewsky, and K. Schwartz. Antithetical accumulation of myosin heavy chain but not alpha -actin mRNA isoforms during early stages of pressure-overload-induced rat cardiac hypertrophy. Circ. Res. 72: 857-864, 1993[Abstract/Free Full Text].

7.   Chien, K. R., Z. Hong, K. U. Knowlton, W. Miller-Hance, M. van-Bilson, T. X. O'Brien, and S. M. Evans. Transcriptional regulation during cardiac growth and development. Annu. Rev. Physiol. 55: 77-95, 1993[Medline].

8.   Chirgwin, J. M., A. E. Przybyla, R. J. MacDonald, and W. J. Rutter. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18: 5294-5299, 1979[Medline].

9.   Chua, B. H. L., L. A. Russo, E. E. Gordon, B. J. Kleinhans, and H. E. Morgan. Faster ribosome synthesis induced by elevated aortic pressure in rat heart. Am. J. Physiol. 252 (Cell Physiol. 21): C323-C327, 1987[Abstract/Free Full Text].

10.   Cooper, G., IV. Cardiocyte adaptation to chronically altered load. Annu. Rev. Physiol. 49: 501-518, 1987[Medline].

11.   Corin, W. J., M. M. Swindle, J. F. Spann, Jr., K. Nakano, M. Frankis, R. W. W. Biederman, A. Smith, A. Taylor, and B. A. Carabello. Mechanism of decreased forward stroke volume in children and swine with ventricular septal defect and failure to thrive. J. Clin. Invest. 82: 544-551, 1988.

12.   Cutilletta, A. F., M. Rudnik, and R. Zak. Muscle and non-muscle cell RNA polymerase activity during the development of myocardial hypertrophy. J. Mol. Cell. Cardiol. 10: 677-687, 1978[Medline].

13.   Grossman, W., D. Jones, and L. P. McLaurin. Wall stress and patterns of hypertrophy in the human left ventricle. J. Clin. Invest. 56: 56-64, 1975.

14.   Hannan, R. D., J. Luyken, and L. I. Rothblum. Regulation of ribosomal DNA transcription during contraction-induced hypertrophy of neonatal cardiomyocytes. J. Biol. Chem. 271: 3213-3220, 1996[Abstract/Free Full Text].

15.   Hasegawa, K., S. J. Lee, S. M. Jobe, B. E. Markham, and R. N. Kitsis. cis-Acting sequences that mediate induction of beta -myosin heavy chain gene expression during left ventricular hypertrophy due to aortic constriction. Circulation 96: 3943-3953, 1997[Abstract/Free Full Text].

16.   Hershey, J. W. B. Translational control in mammalian cells. Annu. Rev. Biochem. 60: 717-755, 1991[Medline].

17.   Imamura, T., P. J. McDermott, R. L. Kent, M. Nagatsu, G. Cooper IV, and B. A. Carabello. Acute changes in myosin heavy chain synthesis rate in pressure versus volume overload. Circ. Res. 75: 418-425, 1994[Abstract/Free Full Text].

18.   Ivester, C. T., R. L. Kent, H. Tagawa, H. Tsutsui, T. Imamura, G. Cooper IV, and P. J. McDermott. Electrically stimulated contraction accelerates protein synthesis rates in adult feline cardiocytes. Am. J. Physiol. 265 (Heart Circ. Physiol. 34): H666-H674, 1993[Abstract/Free Full Text].

19.   Ivester, C. T., W. J. Tuxworth, G. Cooper IV, and P. J. McDermott. Contraction accelerates myosin heavy chain synthesis rates in adult feline cardiocytes by an increase in the rate of translational initiation. J. Biol. Chem. 270: 21950-21957, 1995[Abstract/Free Full Text].

20.   Izumo, S., B. Nadal-Ginard, and V. Mahdavi. Proto-oncogene induction and reprogramming of cardiac gene expression produced by pressure overload. Proc. Natl. Acad. Sci. USA 85: 339-343, 1988[Abstract/Free Full Text].

21.   Joshi, B., A. Cai, B. D. Keiper, W. B. Minich, R. Mendez, C. M. Beach, J. Stepinski, R. Stolarski, E. Darzynkiewicz, and R. E. Rhoads. Phosphorylation of eukaryotic protein synthesis initiation factor 4E at ser-209. J. Biol. Chem. 270: 14597-14603, 1995[Abstract/Free Full Text].

22.   Kent, R. L., and P. J. McDermott. Passive load and angiotensin II evoke differential responses of gene expression and protein synthesis in cardiac myocytes. Circ. Res. 78: 829-838, 1996[Abstract/Free Full Text].

23.   Koide, M., M. Nagatsu, M. R. Zile, M. Hamawaki, M. M. Swindle, G. Keech, G. DeFreyte, H. Tagawa, G. Cooper IV, and B. A. Carabello. Premorbid determinants of left ventricular dysfunction in a novel model of gradually induced pressure overload in the adult canine. Circulation 95: 1601-1610, 1997[Abstract/Free Full Text].

24.   Matsuo, T., B. A. Carabello, Y. Nagatomo, M. Koide, M. Hamawaki, M. R. Zile, and P. J. McDermott. Mechanisms of cardiac hypertrophy in canine volume overload. Am. J. Physiol. 275 (Heart Circ. Physiol. 44): H65-H74, 1998[Abstract/Free Full Text].

25.   McDermott, P. J., L. L. Carl, K. J. Conner, and S. N. Allo. Transcriptional regulation of ribosomal RNA synthesis during growth of cardiac myocytes in culture. J. Biol. Chem. 266: 4409-4416, 1991[Abstract/Free Full Text].

26.   McDermott, P. J., L. I. Rothblum, S. D. Smith, and H. E. Morgan. Accelerated rates of ribosomal RNA synthesis during growth of contracting heart cells in culture. J. Biol. Chem. 264: 18220-18227, 1989[Abstract/Free Full Text].

27.   Mezzetti, G. S., S. Ferrari, P. Davalli, R. Battini, and A. Corti. Peptide chain initiation and analysis of in vitro translation products in rat heart undergoing hypertrophic growth. J. Mol. Cell. Cardiol. 15: 629-635, 1983[Medline].

28.   Minich, W. B., M. L. Balasta, D. J. Goss, and R. E. Rhoads. Chromatographic resolution of in vivo phosphorylated and nonphosphorylated eukaryotic translation initiation factor eIF-4E: increased cap affinity of the phosphorylated form. Proc. Natl. Acad. Sci. USA 91: 7668-7672, 1994[Abstract/Free Full Text].

29.   Molkentin, J. D., S. M. Jobe, and B. E. Markham. alpha -Myosin heavy chain gene regulation: delineation and characterization of the cardiac muscle-specific enhancer and muscle-specific promoter. J. Mol. Cell. Cardiol. 28: 1211-1225, 1996[Medline].

30.   Morgan, H. E., and C. J. Beinlich. Contributions of increased efficiency and capacity of protein synthesis to rapid cardiac growth. Mol. Cell. Biochem. 176: 145-151, 1997[Medline].

31.   Morgan, H. E., E. E. Gordon, Y. Kira, B. H. L. Chua, L. A. Russo, C. J. Peterson, P. J. McDermott, and P. A. Watson. Biochemical mechanisms of cardiac hypertrophy. Annu. Rev. Physiol. 49: 533-543, 1987[Medline].

32.   Nagai, R., R. B. Low, W. S. Stirewalt, N. R. Alpert, and R. Z. Litten. Efficiency and capacity of protein synthesis are increased in pressure overload cardiac hypertrophy. Am. J. Physiol. 255 (Heart Circ. Physiol. 24): H325-H328, 1988[Abstract/Free Full Text].

33.   Nakano, K., M. M. Swindle, F. Spinale, K. Ishihara, S. Kanazawa, A. Smith, R. W. W. Biederman, L. Clamp, Y. Hamada, M. R. Zile, and B. A. Carabello. Depressed contractile function due to canine mitral regurgitation improves after correction of the volume overload. J. Clin. Invest. 87: 2077-2086, 1991.

34.   Ojamaa, K., J. F. Petrie, C. Balkman, C. Hong, and I. Klein. Posttranscriptional modification of myosin heavy-chain gene expression in the hypertrophied rat myocardium. Proc. Natl. Acad. Sci. USA 91: 3468-3472, 1994[Abstract/Free Full Text].

35.   Rackley, C. E., H. T. Dodge, Y. D. Coble, and R. E. Hay. A method for determining left ventricular mass in man. Circulation 29: 666-671, 1964[Abstract/Free Full Text].

36.   Rossi, A., J. Aussedut, J. Olivares, A. Ray, and M. Verdys. Pyrimidine nucleotide metabolism in cardiac hypertrophy. Eur. Heart J. 5, Suppl. F: 155-162, 1984.

37.   Siehl, D., B. H. L. Chua, N. Lautensack-Belser, and H. E. Morgan. Faster protein and ribosome synthesis in thyroxine-induced hypertrophy of rat heart. Am. J. Physiol. 248 (Cell Physiol. 17): C309-C319, 1985[Abstract/Free Full Text].

38.   Tagawa, H., J. D. Rozich, H. Tsutsui, T. Narishige, D. Kuppuswamy, H. Sato, P. J. McDermott, M. Koide, and G. Cooper IV. Basis for increased microtubules in pressure hypertrophied cardiocytes. Circulation 93: 1230-1243, 1996[Abstract/Free Full Text].

39.   Umeda, P. K., D. S. Darling, J. M. Kennedy, S. Jakovcic, and R. Zak. Control of myosin heavy chain expression in cardiac hypertrophy. Am. J. Cardiol. 59: 49A-55A, 1987[Medline].

40.   Wada, H., C. T. Ivester, B. A. Carabello, G. Cooper IV, and P. J. McDermott. Translational initiation factor eIF-4E. A link between cardiac load and protein synthesis. J. Biol. Chem. 271: 8359-8364, 1996[Abstract/Free Full Text].

41.   Wiesner, R. J., H. Ehmke, J. Faulhaber, R. Zak, and J. C. Rüegg. Dissociation of left ventricular hypertrophy, beta -myosin heavy chain gene expression, and myosin isoform switch in rats after ascending aortic stenosis. Circulation 95: 1253-1259, 1997[Abstract/Free Full Text].


Am J Physiol Heart Circ Physiol 277(6):H2176-H2184



This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. Scholz, C. F. Baicu, W. J. Tuxworth, L. Xu, H. Kasiganesan, D. R. Menick, and G. Cooper IV
Microtubule-dependent distribution of mRNA in adult cardiocytes
Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1135 - H1144.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. M. Deschamps, K. A. Apple, A. H. Leonardi, J. E. McLean, W. M. Yarbrough, R. E. Stroud, L. L. Clark, J. A. Sample, and F. G. Spinale
Myocardial Interstitial Matrix Metalloproteinase Activity Is Altered by Mechanical Changes in LV Load: Interaction With the Angiotensin Type 1 Receptor
Circ. Res., May 27, 2005; 96(10): 1110 - 1118.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
G. R. Adams, V. J. Caiozzo, F. Haddad, and K. M. Baldwin
Cellular and molecular responses to increased skeletal muscle loading after irradiation
Am J Physiol Cell Physiol, October 1, 2002; 283(4): C1182 - C1195.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nagatomo, Y.
Right arrow Articles by McDermott, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nagatomo, Y.
Right arrow Articles by McDermott, P. J.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online